Financhill
Back

Aclaris Therapeutics Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison

Sell
6

ACRS
Aclaris Therapeutics

Last Price:
1.18
Seasonality Move:
0.39%
Buy
62

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
45.76
Seasonality Move:
-8.14%
Sell
6
Aclaris Therapeutics (ACRS) is a Sell

Is Aclaris Therapeutics a Buy, Sell or Hold?

  • The current Aclaris Therapeutics [ACRS] share price is $1.18. The Score for ACRS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • ACRS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
62
Corbus Pharmaceuticals Holdings (CRBP) is a Buy

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $44.14. The Score for CRBP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ACRS Stock Price Chart

What is Aclaris Therapeutics's stock price today?

  • The Aclaris Therapeutics share price today is $1.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing slight selling pressure.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

  • The Corbus Pharmaceuticals Holdings share price today is $44.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.

ACRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 43.93 Sell
Chaikin Money Flow: -210009 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.18 - 1.28) Sell
Bollinger Bands (100): (1.12 - 1.28) Sell

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.63 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: -124400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.22 - 42.24) Buy
Bollinger Bands (100): (14.78 - 41.78) Buy

ACRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.23 Sell
20-day SMA: 1.23 Sell
50-day SMA: 1.23 Sell
200-day SMA: 3.18 Sell
8-day EMA: 1.21 Sell
20-day EMA: 1.23 Sell
50-day EMA: 1.25 Sell
200-day EMA: 3.34 Sell

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.2 Buy
20-day SMA: 38.94 Buy
50-day SMA: 39.41 Buy
200-day SMA: 17.1 Buy
8-day EMA: 42.17 Buy
20-day EMA: 40.25 Buy
50-day EMA: 36.89 Buy
200-day EMA: 22.3 Buy

Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.

Aclaris Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):